FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stent, Coronary

PMA: P900043 · Supplement: S028 · Decision Sep 21, 2001
Classifications
1
FEI Numbers
28
Registration Numbers
28

Basic Information

Device Name
Stent, Coronary
Trade Name
BX VELOCITY/HEPACOAT ON RAPTOR STENT SYSTEM
PMA Number
P900043
Supplement Number
S028
Device Class
FDA Class 3
Product Code
MAF
Generic Name
STENT, CORONARY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 21, 2001
Date Received
April 6, 2001
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR A NEW INDICATION (ELECTIVE STENTING OF DE NOVO AND RESTENOTIC CORONARY ARTERIES) AND ADDITIONAL STENT DIAMETERS (4.5 AND 5.0 MM) FOR THE BX VELOCITY WITH HEPACOAT ON STENT SYSTEM. THE DEVICE, AS MODIFIED, IS NOW INDICATED FOR IMPROVING CORONARY LUMINAL DIAMETER IN THE FOLLOWING: 1) FOR TREATMENT OF PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE DUE TO DISCRETE DE NOVO OR RESTENOTIC LESIONS (= 30 MM IN LENGTH IN NATIVE CORONARY ARTERIES WITH REFERENCE DIAMETERS RANGING FROM 3.0 MM TO 5.0 MM; AND 2) FOR TREATMENT OF ABRUPT OR THREATENED VESSEL CLOSURE IN PATIENTS WITH FAILED INTERVENTIONAL THERAPY IN LESIONS (= 30 MM IN LENGTH) WITH REFERENCE DIAMETERS IN THE RANGE OF 2.25 MM IN 4.00 MM. THE 2.25 MM, 2.50 MM, AND 2.75 MM DIAMETERS ARE SOLELY INDICATED FOR USE IN PATIENTS WITH ABRUPT OR THREATENED CLOSURE, AND THE 4.5 AND 5.0 MM DIAMETERS ARE INDICATED SOLELY FOR USE IN PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE DUE TO DISCRETE DE NOVO OR RESTENOTIC LESIONS.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAF Stent, Coronary